GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Edesa Biotech Inc (STU:RBTQ) » Definitions » Net Interest Income

Edesa Biotech (STU:RBTQ) Net Interest Income : €0.24 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Edesa Biotech Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Edesa Biotech's net interest income for the three months ended in Mar. 2024 was €0.04 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2024 was €0.24 Mil.

Edesa Biotech Net Interest Income Historical Data

The historical data trend for Edesa Biotech's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edesa Biotech Net Interest Income Chart

Edesa Biotech Annual Data
Trend Aug14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.03 0.01 0.07 0.27

Edesa Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.07 0.06 0.04

Edesa Biotech Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edesa Biotech Net Interest Income Related Terms

Thank you for viewing the detailed overview of Edesa Biotech's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Edesa Biotech (STU:RBTQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Edesa Biotech Inc (STU:RBTQ) » Definitions » Net Interest Income
Comparable Companies
EIGR SIGY EVLO IMNN GTBP TMBR NHWK GRTX CMRA ONVO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
EDSA:USA
Address
100 Spy Court, Markham, ON, CAN, L3R 5H6
Website
https://www.edesabiotech.com
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Edesa Biotech (STU:RBTQ) Headlines

No Headlines